Long COVID: First Clinical Case Reports Show Significant Improvements in Daily Life – Insights into the Current AlphaH2+ Pilot Observation
16 Jan 2026 News

Long COVID: First Clinical Case Reports Show Significant Improvements in Daily Life – Insights into the Current AlphaH2+ Pilot Observation

Long COVID remains a significant burden for many affected individuals. Persistent fatigue, reduced resilience, breathing problems, and concentration difficulties often shape their daily lives – frequently for months on end.
In our ongoing clinical observation, several participating doctors and medical students are now reporting perceptible alleviation of their symptoms, which is linked to targeted metabolic support.

These reports are part of a systematic evaluation that is currently being expanded and scientifically processed.

Clinical Participation by Dr. Jäger

The observation is supported, among others, by Dr. Jäger (Clinicum St. Georg), who has expressly consented to her personal mention.
She supervises several of the documented cases and reports consistently:

"Patients report a significant improvement in their physical and mental resilience. Particularly noticeable is the stabilization of daily energy and a reduction in exhaustion peaks."
(Quote with kind permission)

This assessment aligns with the directly collected feedback from other participants.

Feedback from other study participants

Several doctors and medical students who themselves suffer from Long COVID or accompany patients consistently report:

  • perceptible improvement in daily energy

  • shorter recovery times after exertion

  • clearer mental presence

  • fewer "crashes" or severe phases of exhaustion

  • more stable stress limits throughout the day

One participant, a medical student in the clinical phase, describes:

"For the first time in weeks, I was able to attend lectures and study sessions for three consecutive days without being completely exhausted."

Other colleagues also report improved stress resilience and a more balanced daily routine.

Important:
These statements are based on anecdotal reports and do not represent claims of efficacy. This is an ongoing observational series that is being scientifically evaluated.

Possible explanation: Metabolic dysregulation in Long COVID

Current studies show that Long COVID is often accompanied by persistent oxidative dysregulation – with effects on:

  • mitochondrial energy production

  • inflammatory processes

  • cellular regeneration

  • oxygen utilization

  • antioxidant capacity

The participating doctors rely on targeted metabolic support to counteract these disturbed processes.

AlphaH2+ is used as a dietary food for special medical purposes, exclusively under medical supervision, as legally stipulated.

The interim observation so far

The anecdotal reports show a consistent pattern:
Participants in the observational series report significant improvements in their functional everyday lives, especially regarding energy, resilience, and regenerative capacity.

This data is currently being incorporated into a comprehensive evaluation, which will be published after the observation is completed.
The involvement of several medical professionals – including Dr. Jäger – provides a particularly practical insight into this complex situation.